[
  {
    "ts": "2026-01-15T01:25:00+00:00",
    "headline": "Ascentage Pharma Outlined its Global Innovation Strategy During Presentation at 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "Two commercialized hematology products, Olverembatinib and Lisaftoclax, drive dual-engine growth with strong China market presenceNext-generation BTK protein degrader APG-3288 receives IND clearance from the U.S. FDA, propelling expansion of global innovative pipelineMultiple global registrational Phase III trials are progressing rapidly ROCKVILLE, Md. and SUZHOU, China, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, commercial stage,",
    "url": "https://finance.yahoo.com/news/ascentage-pharma-outlined-global-innovation-012500120.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "a3c8490f-64dc-3963-ade6-5285cabe5a10",
      "content": {
        "id": "a3c8490f-64dc-3963-ade6-5285cabe5a10",
        "contentType": "STORY",
        "title": "Ascentage Pharma Outlined its Global Innovation Strategy During Presentation at 44th Annual J.P. Morgan Healthcare Conference",
        "description": "",
        "summary": "Two commercialized hematology products, Olverembatinib and Lisaftoclax, drive dual-engine growth with strong China market presenceNext-generation BTK protein degrader APG-3288 receives IND clearance from the U.S. FDA, propelling expansion of global innovative pipelineMultiple global registrational Phase III trials are progressing rapidly ROCKVILLE, Md. and SUZHOU, China, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, commercial stage,",
        "pubDate": "2026-01-15T01:25:00Z",
        "displayTime": "2026-01-15T01:25:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/eec2b2ec03b3e63b4445c46aa13f2fff",
          "originalWidth": 600,
          "originalHeight": 600,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/dTneQnM2Yg50YWgqP0J1jQ--~B/aD02MDA7dz02MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/eec2b2ec03b3e63b4445c46aa13f2fff.cf.webp",
              "width": 600,
              "height": 600,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/uh2FujGP.j4Etsk7I..e8A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/eec2b2ec03b3e63b4445c46aa13f2fff.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/ascentage-pharma-outlined-global-innovation-012500120.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/ascentage-pharma-outlined-global-innovation-012500120.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AAPG"
            },
            {
              "symbol": "ASPHF"
            },
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-15T01:07:03+00:00",
    "headline": "AbCellera Biologics Pivots to Internal Pipeline at JPMorgan, Teases Key Milestones for 2026",
    "summary": "AbCellera Biologics (NASDAQ:ABCL) used its presentation at the 2026 JPMorgan Healthcare Conference to outline its shift from a technology-enabled antibody discovery partner toward a company advancing multiple internal clinical-stage programs, with management emphasizing several upcoming development",
    "url": "https://www.marketbeat.com/instant-alerts/abcellera-biologics-pivots-to-internal-pipeline-at-jpmorgan-teases-key-milestones-for-2026-2026-01-14/?utm_source=yahoofinance&utm_medium=yahoofinance",
    "source": "MarketBeat",
    "provider": "yfinance",
    "raw": {
      "id": "331c8d76-dd71-31c1-a946-6d535d7ef3ae",
      "content": {
        "id": "331c8d76-dd71-31c1-a946-6d535d7ef3ae",
        "contentType": "STORY",
        "title": "AbCellera Biologics Pivots to Internal Pipeline at JPMorgan, Teases Key Milestones for 2026",
        "description": "",
        "summary": "AbCellera Biologics (NASDAQ:ABCL) used its presentation at the 2026 JPMorgan Healthcare Conference to outline its shift from a technology-enabled antibody discovery partner toward a company advancing multiple internal clinical-stage programs, with management emphasizing several upcoming development",
        "pubDate": "2026-01-15T01:07:03Z",
        "displayTime": "2026-01-15T01:07:03Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/marketbeat_955/b6361019a7432d351832cc8a575a27f6",
          "originalWidth": 1200,
          "originalHeight": 675,
          "caption": "AbCellera Biologics logo",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/bSMSi8UHH11PKq4lxFbWjA--~B/aD02NzU7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/marketbeat_955/b6361019a7432d351832cc8a575a27f6.cf.webp",
              "width": 1200,
              "height": 675,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/GaSeD6cCk56LKjYNyhOlBA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/marketbeat_955/b6361019a7432d351832cc8a575a27f6.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "MarketBeat",
          "url": "https://www.marketbeat.com/"
        },
        "canonicalUrl": {
          "url": "https://www.marketbeat.com/instant-alerts/abcellera-biologics-pivots-to-internal-pipeline-at-jpmorgan-teases-key-milestones-for-2026-2026-01-14/?utm_source=yahoofinance&utm_medium=yahoofinance",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/abcellera-biologics-pivots-internal-pipeline-010703388.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JPM"
            },
            {
              "symbol": "ABCL"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-15T00:40:00+00:00",
    "headline": "Samsung Epis Holdings Delivers Business Updates at the 44th J.P. Morgan Healthcare Conference",
    "summary": "INCHEON, Korea, January 15, 2026--Samsung Epis Holdings shared corporate progress and updates at the 44th J.P. Morgan Healthcare Conference.",
    "url": "https://finance.yahoo.com/news/samsung-epis-holdings-delivers-business-004000461.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "732915b2-27a1-364e-a1a4-bedc2fd7bd6f",
      "content": {
        "id": "732915b2-27a1-364e-a1a4-bedc2fd7bd6f",
        "contentType": "STORY",
        "title": "Samsung Epis Holdings Delivers Business Updates at the 44th J.P. Morgan Healthcare Conference",
        "description": "",
        "summary": "INCHEON, Korea, January 15, 2026--Samsung Epis Holdings shared corporate progress and updates at the 44th J.P. Morgan Healthcare Conference.",
        "pubDate": "2026-01-15T00:40:00Z",
        "displayTime": "2026-01-15T00:40:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/b1facebe228216e696f145ee4657e618",
          "originalWidth": 480,
          "originalHeight": 420,
          "caption": "Kyung-Ah Kim, President and Chief Executive Officer (CEO) of Samsung Epis Holdings",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/6QrBlzWy0pfhSy4NFrczoA--~B/aD00MjA7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/b1facebe228216e696f145ee4657e618.cf.webp",
              "width": 480,
              "height": 420,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/YXXoJ5jLh_XDCtOMLICdbQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/b1facebe228216e696f145ee4657e618.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/samsung-epis-holdings-delivers-business-004000461.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/samsung-epis-holdings-delivers-business-004000461.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "0126Z0.KS"
            },
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-15T02:00:00+00:00",
    "headline": "iFAST Partners BlackRock and JPMorgan to Drive Discretionary Portfolio Adoption Among Wealth Advisers",
    "summary": "iFAST Financial Singapore (\"iFAST\"), a wholly-owned subsidiary of iFAST Corporation Ltd, announced an expansion to its Discretionary Portfolio Management Solutions (DPMS) lineup with the launch of new portfolios advised by BlackRock and J.P. Morgan Asset Management (\"JPMorgan\") respectively.",
    "url": "https://finance.yahoo.com/news/ifast-partners-blackrock-jpmorgan-drive-020000437.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "e4a49b74-e285-3430-b0c5-373c0204ad83",
      "content": {
        "id": "e4a49b74-e285-3430-b0c5-373c0204ad83",
        "contentType": "STORY",
        "title": "iFAST Partners BlackRock and JPMorgan to Drive Discretionary Portfolio Adoption Among Wealth Advisers",
        "description": "",
        "summary": "iFAST Financial Singapore (\"iFAST\"), a wholly-owned subsidiary of iFAST Corporation Ltd, announced an expansion to its Discretionary Portfolio Management Solutions (DPMS) lineup with the launch of new portfolios advised by BlackRock and J.P. Morgan Asset Management (\"JPMorgan\") respectively.",
        "pubDate": "2026-01-15T02:00:00Z",
        "displayTime": "2026-01-15T02:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/fe64b94d8e9bbcb763bb5a852972b00a",
          "originalWidth": 16,
          "originalHeight": 16,
          "caption": "Cision",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/HzmDhenNsArXlak55qzIlg--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/fe64b94d8e9bbcb763bb5a852972b00a.cf.webp",
              "width": 16,
              "height": 16,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/kwFRV_7Bmqtyuax0qimDjQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/fe64b94d8e9bbcb763bb5a852972b00a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/ifast-partners-blackrock-jpmorgan-drive-020000437.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/ifast-partners-blackrock-jpmorgan-drive-020000437.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JPM"
            },
            {
              "symbol": "BLK"
            },
            {
              "symbol": "AIY.SI"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-15T02:00:00+00:00",
    "headline": "Jamie Dimon Seemed to Have Trump Figured Out—Until This Week",
    "summary": "JPMorgan’s CEO had been rebuilding his relationship with the president, but the fight over Fed chair Powell threatens to blow it up again.",
    "url": "https://www.wsj.com/politics/policy/jamie-dimon-trump-jpmorgan-3d63a020?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "7f91c0e6-1552-31a6-af8a-822bfd65648a",
      "content": {
        "id": "7f91c0e6-1552-31a6-af8a-822bfd65648a",
        "contentType": "STORY",
        "title": "Jamie Dimon Seemed to Have Trump Figured Out—Until This Week",
        "description": "",
        "summary": "JPMorgan’s CEO had been rebuilding his relationship with the president, but the fight over Fed chair Powell threatens to blow it up again.",
        "pubDate": "2026-01-15T02:00:00Z",
        "displayTime": "2026-01-15T02:00:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/7f91c0e6-1552-31a6-af8a-822bfd65648a/jamie-dimon-seemed-to-have.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/264675c1656266d9a3a4f98e98aa824f",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/v4axxp7gJqDXaJnvCGCJqg--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/264675c1656266d9a3a4f98e98aa824f.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/dZlFweIm7hSFBMb6Zxcrpw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/264675c1656266d9a3a4f98e98aa824f.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/politics/policy/jamie-dimon-trump-jpmorgan-3d63a020?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-15T07:07:24+00:00",
    "headline": "Is Executive Exit And Cautious Guidance Altering The Investment Case For Zimmer Biomet (ZBH)?",
    "summary": "Zimmer Biomet Holdings, Inc. recently disclosed that former executive officer Mark Bezjak will resign from the company on January 16, 2026, while management has also struck a cautious tone on future performance and guidance at the J.P. Morgan Healthcare Conference. These developments come as CEO Ivan Tornos prepares a major direct-to-consumer campaign and emphasizes realistic expectations around the company’s transformation plans through 2026. We’ll now examine how management’s more cautious...",
    "url": "https://finance.yahoo.com/news/executive-exit-cautious-guidance-altering-070724280.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "bcb7af14-e982-31c2-8f19-f38f3a7ff5a0",
      "content": {
        "id": "bcb7af14-e982-31c2-8f19-f38f3a7ff5a0",
        "contentType": "STORY",
        "title": "Is Executive Exit And Cautious Guidance Altering The Investment Case For Zimmer Biomet (ZBH)?",
        "description": "",
        "summary": "Zimmer Biomet Holdings, Inc. recently disclosed that former executive officer Mark Bezjak will resign from the company on January 16, 2026, while management has also struck a cautious tone on future performance and guidance at the J.P. Morgan Healthcare Conference. These developments come as CEO Ivan Tornos prepares a major direct-to-consumer campaign and emphasizes realistic expectations around the company’s transformation plans through 2026. We’ll now examine how management’s more cautious...",
        "pubDate": "2026-01-15T07:07:24Z",
        "displayTime": "2026-01-15T07:07:24Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/b23fe2923663ce315e2ef7ba313db8b9",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/qYSQ6AG4c18KIEG8bfQS1g--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/b23fe2923663ce315e2ef7ba313db8b9.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/mH32bjf22B8VXoaGCZudBg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/b23fe2923663ce315e2ef7ba313db8b9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/executive-exit-cautious-guidance-altering-070724280.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/executive-exit-cautious-guidance-altering-070724280.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ZBH"
            },
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-15T06:09:18+00:00",
    "headline": "How The Evolving Story On NMI Holdings (NMIH) Is Shaping Fresh Views On Valuation",
    "summary": "NMI Holdings has just seen a small lift in its fair value estimate, rising from US$44.14 to US$45.14, alongside a slightly lower discount rate assumption of 7.64% instead of 7.72%. These tweaks reflect recent Street research that balances confidence in a stable credit backdrop and potential support from a stronger mortgage origination market in 2026 with ongoing caution around sector regulation and volatility. Stay tuned to see how you can keep track of these kinds of narrative shifts as they...",
    "url": "https://finance.yahoo.com/news/evolving-story-nmi-holdings-nmih-060918826.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "32f7bebb-a41c-3d4b-8888-d4b1906074e9",
      "content": {
        "id": "32f7bebb-a41c-3d4b-8888-d4b1906074e9",
        "contentType": "STORY",
        "title": "How The Evolving Story On NMI Holdings (NMIH) Is Shaping Fresh Views On Valuation",
        "description": "",
        "summary": "NMI Holdings has just seen a small lift in its fair value estimate, rising from US$44.14 to US$45.14, alongside a slightly lower discount rate assumption of 7.64% instead of 7.72%. These tweaks reflect recent Street research that balances confidence in a stable credit backdrop and potential support from a stronger mortgage origination market in 2026 with ongoing caution around sector regulation and volatility. Stay tuned to see how you can keep track of these kinds of narrative shifts as they...",
        "pubDate": "2026-01-15T06:09:18Z",
        "displayTime": "2026-01-15T06:09:18Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/c355483febd8e77cc0daa4c43dbcf2ca",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ncIYWIvldHZ.a3pp67dIaw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/c355483febd8e77cc0daa4c43dbcf2ca.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/JzWqurkBvpMsA11xfsDSTg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/c355483febd8e77cc0daa4c43dbcf2ca.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/evolving-story-nmi-holdings-nmih-060918826.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/evolving-story-nmi-holdings-nmih-060918826.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NMIH"
            },
            {
              "symbol": "BCS"
            },
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]